6533b830fe1ef96bd1296eb0
RESEARCH PRODUCT
Characterization of myofibroblasts isolated from the intestine of patients with inflammatory bowel disease
Ernest G. SeidmanSerge DionneCarl Frederic DuchatellierSophie RestelliniPedro Salvador EscribanoPedro Salvador EscribanoBarry SteinPatrick CharleboisCiriaco A. PiccirilloJamie KoenekoopA. Sender Libermansubject
0301 basic medicineCrohn's diseaseGeneral Immunology and Microbiologybusiness.industrymedicine.medical_treatmentGeneral Medicinemedicine.diseaseInflammatory bowel diseaseGeneral Biochemistry Genetics and Molecular BiologyCTGF03 medical and health sciences030104 developmental biology0302 clinical medicineCytokineInterstitial matrixFibrosismedicineCancer research030211 gastroenterology & hepatologyTumor necrosis factor alphaGeneral Pharmacology Toxicology and PharmaceuticsbusinessTIMP1description
Background: Intestinal fibrosis represents a serious complication of inflammatory bowel diseases (IBD), often necessitating surgical resections. Myofibroblasts are primarily responsible for interstitial matrix accumulation in fibrotic diseases. However intestinal myofibroblasts (IMF) remain inadequately characterized. The aim was to examine fibroblast markers and fibrosis-associated gene expression in IMF isolated from resected intestine from IBD and control patients. As well as determining the effect of the fibrogenic cytokine TGFβ. Methods: Intestinal resections were obtained (n =35) from consenting patients undergoing elective surgery (2014-16). Primary cultures of IMF were isolated using DTT and EDTA and cultured. Viability and phenotypic characterization of IMF was carried out by flow cytometry and fluorescence microscopy. IMF (passages 3-8) were treated for 24 hours. Cytokines were quantified in IMF by real time PCR and in supernatants using the human pro-inflammatory cytokine panel Results: All markers and most fibrosis mediators studied were preferentially expressed by IMF compared to mucosal tissue. Metalloproteinases (MMP) 2 and 3, as well as their inhibitor TIMP1, are highly expressed by IMF. They also highly expressed inflammatory mediators, including IL-6, IL-8, CCL2 and PTGS2. Whereas mucosal expression of pro-inflammatory cytokines such as TNFα and IL-17 is increased in IBD, that of fibrosis mediators was not different. Fibrosis-related gene expression in IMF from IBD patients and controls was similar, but IMF from IBD expressed higher levels of several inflammatory genes. IMF from CD and UC had mostly similar expression profiles. TGFβ induced expression of fibrogenic genes αSMA, COL1A1, CTGF, FN1 and LOX. TGFβ-stimulated IMF released increased levels of IL-6, whereas IL-6, IL-8, as well as small amounts of IFN-γ and IL12p70 were produced following stimulation with IL-1β+IL-23. Conclusions: This study extends knowledge about the pathogenesis of fibrosis in IBD. Further research in the identification of mechanisms involved in IMF activation and fibrogenesis are required.
| year | journal | country | edition | language |
|---|---|---|---|---|
| 2019-03-11 | F1000Research |